Atossa Therapeutics, Inc. (ATOS)
2.42
-0.04
(-1.63%)
USD |
NASDAQ |
Oct 08, 16:00
2.42
0.00 (0.00%)
After-Hours: 20:00
Atossa Therapeutics Price : 2.42 for Oct. 8, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 08, 2026 | 2.46 | 2.478 | 2.385 | 2.42 | 101012.0 |
| Oct 07, 2026 | 2.41 | 2.49 | 2.41 | 2.46 | 19070.00 |
| Oct 06, 2026 | 2.46 | 2.54 | 2.43 | 2.45 | 54625.00 |
| Oct 05, 2026 | 2.38 | 2.500 | 2.341 | 2.45 | 53315.00 |
| Oct 02, 2026 | 2.23 | 2.379 | 2.17 | 2.34 | 74272.00 |
| Oct 01, 2026 | 1.96 | 2.30 | 1.96 | 2.27 | 113600.0 |
| Sep 30, 2026 | 1.99 | 2.15 | 1.95 | 1.95 | 67768.00 |
| Sep 29, 2026 | 2.06 | 2.16 | 1.96 | 1.99 | 83319.00 |
| Sep 28, 2026 | 1.905 | 2.04 | 1.82 | 1.96 | 152933.0 |
| Sep 25, 2026 | 2.06 | 2.065 | 1.89 | 1.90 | 77844.00 |
| Sep 24, 2026 | 2.15 | 2.22 | 2.05 | 2.05 | 37461.00 |
| Sep 23, 2026 | 2.25 | 2.26 | 2.15 | 2.18 | 37188.00 |
| Sep 22, 2026 | 2.25 | 2.43 | 2.25 | 2.26 | 129526.0 |
| Sep 21, 2026 | 2.25 | 2.39 | 2.25 | 2.25 | 67170.00 |
| Sep 18, 2026 | 2.37 | 2.38 | 2.22 | 2.22 | 39756.00 |
| Sep 17, 2026 | 2.42 | 2.43 | 2.37 | 2.40 | 33289.00 |
| Sep 16, 2026 | 2.39 | 2.48 | 2.39 | 2.42 | 45777.00 |
| Sep 15, 2026 | 2.475 | 2.49 | 2.37 | 2.37 | 43779.00 |
| Sep 14, 2026 | 2.53 | 2.555 | 2.45 | 2.48 | 35040.00 |
| Sep 11, 2026 | 2.36 | 2.54 | 2.36 | 2.51 | 60410.00 |
| Sep 10, 2026 | 2.36 | 2.61 | 2.33 | 2.34 | 47238.00 |
| Sep 09, 2026 | 2.54 | 2.54 | 2.40 | 2.40 | 24800.00 |
| Sep 08, 2026 | 2.49 | 2.587 | 2.445 | 2.515 | 41370.00 |
| Sep 04, 2026 | 2.51 | 2.60 | 2.50 | 2.52 | 28028.00 |
| Sep 03, 2026 | 2.50 | 2.60 | 2.46 | 2.53 | 56692.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Immix Biopharma, Inc. | 9.29 |
| ACADIA Pharmaceuticals, Inc. | 19.58 |
| Alnylam Pharmaceuticals, Inc. | 224.53 |
| Savara, Inc. | 4.83 |
| Vericel Corp. | 40.05 |
Price Related Metrics
| PEG Ratio | -0.0041 |
| Price to Book Value | 0.9001 |
| Earnings Yield | -179.5% |
| Market Cap | 24.15M |
| PEGY Ratio | -0.0041 |